| Posted: January 12, 2007 |
Nanotechnology-based medicines nearing commercialization |
|
(Nanowerk News) Innovations at the intersection of medicine, biotechnology, engineering, physical sciences and information technology are spurring new directions in R&D, commercialization and technology transfer. Basic research in nanomedicine and bionanotechnology is rapidly producing commercially viable products. Governments and industries across the globe are staking their claims by investing billions for research. Clearly, international rivalries are growing and political alliances and battle lines are beginning to gel.
|
 |
|
The nanotech community will gather at ALM's Strategic Research Institute's "2nd Annual NANOMEDICINE: Commercializing Drug Delivery, Diagnostics and Medical Devices" conference for two days on March 26-27, 2007 in Arlington, VA to discuss the most important applications of nanotechnology in drug delivery, diagnostics and medical devices.
|
|
The two-day event will consist of presentations, panels and networking opportunities, providing insights into trends in nanomedicine, dissociating myths from realities and highlighting future areas of commercial potential. The previous conference was so successful that a front-page lead cover story covering the conference appeared in Genetic Engineering News.
|
|
The 2007 event will focus on cutting-edge R&D, commercialization strategies, policy, regulatory and IP issues – offering networking opportunities to researchers from industry, government and academia; physicians; intellectual property practitioners; business and economic development professionals; technology transfer specialists, policy makers and venture capitalists.
|
|
For more information on registration, potential speaking engagements, or sponsorship/exhibition opportunities, please contact the organizer, Jon E. Liong of Strategic Research Institute at or call (212) 967-0095 ext. 243.
|
